Your browser is no longer supported. Please, upgrade your browser.
Settings
NURO NeuroMetrix, Inc. daily Stock Chart
NURO [NASD]
NeuroMetrix, Inc.
Index- P/E- EPS (ttm)-6.69 Insider Own3.90% Shs Outstand7.15M Perf Week0.78%
Market Cap9.29M Forward P/E- EPS next Y-4.22 Insider Trans12.70% Shs Float7.07M Perf Month4.00%
Income-11.30M PEG- EPS next Q- Inst Own14.70% Short Float5.14% Perf Quarter-5.80%
Sales17.70M P/S0.53 EPS this Y80.10% Inst Trans- Short Ratio1.53 Perf Half Y-27.37%
Book/sh1.08 P/B1.20 EPS next Y- ROA-119.70% Target Price3.00 Perf Year-39.53%
Cash/sh0.85 P/C1.52 EPS next 5Y15.00% ROE-214.80% 52W Range1.20 - 2.96 Perf YTD-24.81%
Dividend- P/FCF- EPS past 5Y41.30% ROI-261.70% 52W High-56.08% Beta0.37
Dividend %- Quick Ratio2.10 Sales past 5Y17.70% Gross Margin40.80% 52W Low8.33% ATR0.08
Employees41 Current Ratio2.50 Sales Q/Q14.00% Oper. Margin-49.30% RSI (14)47.46 Volatility3.25% 6.66%
OptionableNo Debt/Eq0.00 EPS Q/Q101.20% Profit Margin-63.70% Rel Volume0.15 Prev Close1.29
ShortableYes LT Debt/Eq0.00 EarningsJul 19 BMO Payout- Avg Volume237.65K Price1.30
Recom3.00 SMA20-0.92% SMA50-3.44% SMA200-17.57% Volume35,333 Change0.78%
Oct-20-17Reiterated H.C. Wainwright Buy $10 → $3
Jun-28-16Initiated Rodman & Renshaw Buy $4.50
Sep-11-15Initiated Maxim Group Buy $2
Feb-27-12Initiated Dawson James Buy $3
Jul-12-18 11:00AM  NeuroMetrix, Inc. Announces Date for 2018 Second Quarter Financial Results Conference Call GlobeNewswire
Jul-05-18 01:00PM  NeuroMetrix Announces Issuance of New U.S. Patent for DPNCheck Point-of-Care Neuropathy Test Technology GlobeNewswire
Jun-28-18 12:27PM  NeuroMetrix PR Campaign Wins Gold at the Publicity Club of New England 2018 Bell Ringer Awards GlobeNewswire
Jun-26-18 11:00AM  NeuroMetrix Reports Publication of New Clinical Studies on DPNCheck GlobeNewswire +7.75%
Jun-21-18 11:00AM  NeuroMetrix Report Highlights Stigma Faced by Chronic Pain Community around Opioid Use, Desire for Alternative Treatments GlobeNewswire
Jun-20-18 08:00AM  Today's Research Reports on Stocks to Watch: Neptune Technologies & Bioressources and NeuroMetrix ACCESSWIRE -8.78%
Jun-19-18 08:44AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga +19.26%
07:00AM  NeuroMetrix Receives $3.8M Milestone Payment Under Its Collaboration with GSK Consumer Healthcare GlobeNewswire
Jun-11-18 06:12PM  Is NeuroMetrix Incs (NASDAQ:NURO) CEO Paid At A Competitive Rate? Simply Wall St.
May-24-18 12:27PM  NeuroMetrix Inc (NASDAQ:NURO): What Does It Mean For Your Portfolio? Simply Wall St.
May-11-18 07:10AM  Free Technical Snapshots for Ekso Bionics and Three More Medical Supplies Stocks ACCESSWIRE
May-03-18 11:00AM  Preliminary Results from Quell Chronic Low Back Pain Study to be Presented at World Institute of Pain World Congress GlobeNewswire
May-01-18 11:00AM  NeuroMetrix, Inc. to Participate in Upcoming Disruptive Growth & Healthcare Conference in New York City GlobeNewswire
Apr-24-18 11:00AM  NeuroMetrix to Present Quell Data at Upcoming American Academy of Pain Medicine Annual Meeting GlobeNewswire
Apr-19-18 07:00AM  NeuroMetrix Reports Q1 2018 Financial Results GlobeNewswire -7.05%
06:15AM  NeuroMetrix, Inc. to Host Earnings Call ACCESSWIRE
Apr-18-18 02:00PM  NeuroMetrix to Present Data on Quell Sleep Monitoring Technology at Upcoming American Academy of Neurology Annual Meeting GlobeNewswire
Apr-11-18 11:00AM  NeuroMetrix, Inc. Announces Date for 2018 First Quarter Financial Results Conference Call GlobeNewswire -6.90%
Apr-10-18 02:30PM  NeuroMetrix Reports Results of Large Clinical Study of Quell Wearable Pain Relief GlobeNewswire +9.02%
Mar-08-18 02:35PM  Should You Buy NeuroMetrix Inc (NASDAQ:NURO) Now? Simply Wall St.
Mar-01-18 11:00AM  NeuroMetrix to Present Quell Data at 2018 American Pain Society Meeting GlobeNewswire
Feb-08-18 01:48PM  NeuroMetrix Inc (NURO) Files 10-K for the Fiscal Year Ended on December 31, 2017 GuruFocus.com -5.44%
Jan-25-18 06:09PM  Edited Transcript of NURO earnings conference call or presentation 25-Jan-18 1:00pm GMT Thomson Reuters StreetEvents -9.18%
07:00AM  NeuroMetrix Reports Q4 and Full Year 2017 Financial Results GlobeNewswire
Jan-19-18 07:40AM  Unknown BTCY May Have Big Upside Ahead of Likely Near-Term FDA Approval ACCESSWIRE -7.21%
Jan-18-18 11:40AM  NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2017 Financial Results Conference Call GlobeNewswire
Jan-17-18 02:13PM  Heres Why Neurometrix Inc Rose as Much as 60% Today SmarterAnalyst +20.35%
11:17AM  7 Stocks Move in Premarket Trade Wednesday GuruFocus.com
07:25AM  NeuroMetrix's stock soars in active trade after collaboration with GlaxoSmithKline on Quell MarketWatch
07:00AM  NeuroMetrix and GlaxoSmithKline Consumer Healthcare Announce Strategic Collaboration to Develop and Expand Access to Quell Wearable Pain Relief Technology GlobeNewswire
Jan-08-18 07:00AM  NeuroMetrix Reports Preliminary 2017 Financial Highlights GlobeNewswire
Jan-04-18 11:00AM  NeuroMetrix CEO to Participate in CES 2018 Panel on Opioid Crisis GlobeNewswire +6.29%
Jan-03-18 11:00AM  NeuroMetrix to Present at Upcoming Biotech Showcase and Digital Medicine Showcase Conferences GlobeNewswire
Nov-29-17 10:09AM  NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology Business Wire -14.43%
Nov-16-17 10:27AM  Interested In The Healthcare Industry? Take A Look At NeuroMetrix Inc (NURO) Simply Wall St. +8.81%
Nov-01-17 02:45PM  What Is NeuroMetrix Incs (NURO) Share Price Doing? Simply Wall St.
Oct-31-17 10:07AM  NeuroMetrix Closes $3.5 Million Equity Offering Business Wire
Oct-24-17 08:42AM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q3, 2017 By the Numbers : October 24, 2017 Capital Cube
Oct-20-17 01:31AM  Edited Transcript of NURO earnings conference call or presentation 19-Oct-17 12:00pm GMT Thomson Reuters StreetEvents
Oct-19-17 07:00AM  NeuroMetrix Reports Q3 2017 Financial Results Business Wire -8.99%
06:00AM  Investor Network: NeuroMetrix, Inc. to Host Earnings Call ACCESSWIRE
Oct-10-17 10:00AM  NeuroMetrix, Inc. Announces Date for 2017 Third Quarter Financial Results Conference Call Business Wire
Sep-18-17 03:37PM  Before You Buy NeuroMetrix Incs (NURO), You Should Consider This Simply Wall St.
Sep-05-17 01:00PM  NeuroMetrix Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City September 10-12th, 2017 Business Wire
Aug-31-17 03:32PM  Two Studies Derived from Quell Health Cloud to be Presented at Upcoming PAINWeek National Conference Business Wire
Aug-29-17 09:53AM  NeuroMetrix Teams Up with U.S. Pain Foundation to Raise Awareness of Chronic Pain Business Wire
Aug-17-17 07:40AM  Featured Company News - NeuroMetrix Announces Issuance of New US Patent for Automated Control of Quell(R) Therapy During Sleep ACCESSWIRE
Aug-15-17 07:00AM  NeuroMetrix Announces Issuance of New U.S. Patent for Automated Control of Quell Therapy During Sleep Business Wire
Aug-13-17 12:55AM  Edited Transcript of NURO earnings conference call or presentation 20-Jul-17 12:00pm GMT Thomson Reuters StreetEvents
Aug-03-17 10:13AM  NeuroMetrix Announces DPNCheck Distribution Agreement with Fukuda Denshi in Japan Business Wire
Jul-27-17 01:01PM  NeuroMetrix Announces Shipment of 100,000th Quell Device Since Launch in 2015 Business Wire
Jul-26-17 07:10AM  Featured Company News - FDA Gives Market Clearance to Teleflex's Arrow(R) Seldinger Arterial Catheterization Device Accesswire
Jul-24-17 11:41AM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q2, 2017 By the Numbers : July 24, 2017 Capital Cube +6.53%
Jul-20-17 07:00AM  NeuroMetrix Reports Q2 2017 Financial Results Business Wire -7.76%
06:10AM  Investor Network: NeuroMetrix, Inc. to Host Earnings Call Accesswire
Jul-13-17 07:00AM  NeuroMetrix, Inc. Announces Date for 2017 Second Quarter Financial Results Conference Call Business Wire
Jul-10-17 06:24PM  NeuroMetrix Announces $7.0 Million Private Placement of Preferred Stock Business Wire
Jul-06-17 07:00AM  NeuroMetrix Reports Promotion of Michael MacDonald to Senior Vice President and General Manager of Diagnostics Business Wire
Jun-26-17 12:37PM  NeuroMetrix Provides Update on Quell Health Cloud Including Promotion of Dr. Xuan Kong to Chief Data Scientist Business Wire
Jun-23-17 11:05AM  NeuroMetrix Provides Update on Quell Wearable Pain Relief Clinical Program Business Wire
Jun-14-17 08:00AM  Today's Research Reports on Stocks to Watch: Cleantech Solutions and NeuroMetrix Accesswire -5.31%
Jun-13-17 07:00AM  NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Pain Relief Technology Business Wire
Jun-08-17 07:00AM  NeuroMetrix to Present at the Marcum Microcap Conference on June 16, 2017 Business Wire
Jun-06-17 09:42AM  NeuroMetrix Exhibits Quell Wearable Technology at 31st Annual SLEEP Meeting Business Wire
May-30-17 07:00AM  NeuroMetrix to Present at the LD Micro Invitational Conference on June 6, 2017 Business Wire
May-22-17 12:07PM  NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Pain Relief Technology Business Wire -6.77%
May-17-17 11:00AM  NeuroMetrix Wins SBANE New England Innovation Award Business Wire
May-16-17 08:00AM  NeuroMetrix Launches the LivingQuell Blog, a New Platform for Exploring Perspectives on Chronic Pain Business Wire
May-15-17 10:30AM  Preliminary Results from Clinical Study Evaluating Use of Quell in Chemotherapy-Induced Peripheral Neuropathy to be presented at the American Pain Society Annual Meeting Business Wire
May-11-17 11:45AM  NeuroMetrix Announces One-for-Eight Reverse Split Business Wire
May-08-17 11:04AM  NeuroMetrix Reports Substantial Expansion of International Intellectual Property Assets for Quell Wearable Pain Relief Technology Business Wire
May-05-17 01:02PM  NeuroMetrix Hosts Inaugural Quell User Event Business Wire
Apr-21-17 07:26PM  Edited Transcript of NURO earnings conference call or presentation 20-Apr-17 12:00pm GMT Thomson Reuters StreetEvents +5.69%
10:50AM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q1, 2017 By the Numbers : April 21, 2017 Capital Cube
Apr-20-17 07:00AM  NeuroMetrix Reports Q1 2017 Financial Results Business Wire -5.37%
Apr-19-17 08:30AM  NeuroMetrix Review Ahead of Thursday's Earnings Call Accesswire -5.65%
Apr-18-17 11:34AM  NeuroMetrix Announces Availability of Quell Wearable Pain Relief Technology at Bed Bath & Beyond Business Wire +16.70%
Apr-13-17 10:00AM  NeuroMetrix Named a 50+ Innovation Leader Business Wire
Apr-12-17 10:52AM  NeuroMetrix, Inc. Announces Date for 2017 First Quarter Financial Results Conference Call Business Wire +5.26%
Mar-17-17 12:01PM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017 Capital Cube +6.25%
12:01PM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017
Mar-15-17 11:55AM  NeuroMetrix Brings Quell Wearable for Pain Relief to American Academy of Pain Medicine 33rd Annual Meeting Business Wire
Mar-01-17 12:20PM  NeuroMetrix Gaining Increased Media Coverage of Quell Wearable Pain Relief Technology in 2017 Business Wire
Feb-28-17 06:39PM  NEUROMETRIX, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -5.32%
Feb-21-17 11:00AM  NeuroMetrix Announces Availability of Quell Wearable Pain Relief Technology at Best Buy Business Wire
Feb-15-17 01:04PM  NEUROMETRIX, INC. Financials
Feb-09-17 05:03PM  NEUROMETRIX, INC. Files SEC form 10-K, Annual Report
Feb-03-17 05:12PM  NEUROMETRIX, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard;
Jan-27-17 09:55AM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: 2016 By the Numbers : January 27, 2017 Capital Cube -5.83%
09:55AM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: 2016 By the Numbers : January 27, 2017
Jan-26-17 08:00AM  NeuroMetrix Inc Earnings Call scheduled for 8:00 am ET today +6.85%
07:09AM  NEUROMETRIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
07:07AM  Q4 2016 NeuroMetrix Inc Earnings Release - Before Market Open
07:00AM  NeuroMetrix Reports Q4 and Full Year 2016 Financial Results Business Wire
Jan-20-17 09:40AM  NeuroMetrix, Inc. Announces Date for 2016 Full Year and Fourth Quarter Financial Results Conference Call Business Wire
Jan-10-17 07:00AM  NeuroMetrix Reports Strong Quell Demand in Q4 2016 Business Wire +10.89%
Jan-06-17 09:25AM  NeuroMetrix to Present at the Digital Medicine Showcase 2017: At the Intersection of Technology and Medicine Business Wire
Jan-05-17 10:34AM  NeuroMetrix Closes $7.0 Million Private Placement of Preferred Stock and Warrants Business Wire
Jan-03-17 03:14PM  NeuroMetrix to Present at Biotech Showcase 2017 Business Wire
12:00PM  CES 2017: NeuroMetrix Brings Life-Enhancing Technology to Those Suffering from Chronic Pain Business Wire
NeuroMetrix, Inc., a healthcare company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. The company develops wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests to address chronic health conditions, including chronic pain, sleep disorders, and diabetes. Its marketed products include Quell, a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems; DPNCheck, a test used to evaluate systemic neuropathies, such as diabetic peripheral neuropathy; ADVANCE system, a platform for the performance of traditional nerve conduction studies; and SENSUS, a pain therapy device based on transcutaneous electrical nerve stimulation for relief of chronic intractable pain. The company offers its products to consumers, retail merchandisers, direct response TV promoters, health care professionals, managed care organizations, endocrinologists, podiatrists, physicians, neurologists, and physical medicine and rehabilitation centers, as well as primary care, internal medicine, orthopedic, hand, and neurosurgeons. It operates in the United States, Europe, Asia, the Middle East, Mexico, and internationally. NeuroMetrix, Inc. was founded in 1996 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gozani ShaiPresident & CEOMar 02Buy1.291,0001,29477,196Mar 02 10:50 AM
Gozani ShaiPresident & CEOFeb 23Buy1.541,5002,31076,196Feb 23 10:47 AM
Gozani ShaiPresident & CEOFeb 21Buy1.451,0001,45374,696Feb 21 11:22 AM
HIGGINS THOMAS TSenior Vice President, CFOFeb 20Buy1.361,5002,04032,463Feb 20 04:25 PM
Gozani ShaiPresident & CEOFeb 20Buy1.361,0001,36373,696Feb 20 11:56 AM
Gozani ShaiPresident & CEOFeb 13Buy1.371,5002,05872,696Feb 13 11:06 AM
MCGILLIN FRANCIS XSVP, Chief Commercial OfficerFeb 12Buy1.303,8495,0008,584Feb 12 10:59 AM
HIGGINS THOMAS TSenior Vice President, CFOFeb 12Buy1.341,5002,01029,963Feb 12 09:59 AM
HIGGINS THOMAS TSenior Vice President, CFOFeb 12Buy1.341,0001,33630,963Feb 12 04:07 PM
Gozani ShaiPresident & CEOFeb 09Buy1.285,0006,37571,196Feb 09 12:29 PM
HIGGINS THOMAS TSenior Vice President, CFOFeb 06Buy1.451,0001,45428,463Feb 06 04:11 PM
Gozani ShaiPresident & CEOFeb 05Buy1.485,0007,38066,196Feb 05 01:32 PM
Gozani ShaiPresident & CEOFeb 01Buy1.622,0003,23161,196Feb 01 04:16 PM
HIGGINS THOMAS TSenior Vice President, CFOFeb 01Buy1.552,5003,88427,463Feb 01 04:16 PM
Gozani ShaiPresident & CEOJan 31Buy1.692,0003,39059,196Jan 31 04:03 PM
Gozani ShaiPresident & CEOJan 29Buy1.751,0001,75057,196Jan 29 04:35 PM
Gozani ShaiPresident & CEODec 13Buy1.783,0005,32756,196Dec 13 04:11 PM
Gozani ShaiPresident & CEODec 12Buy1.762,0003,52753,196Dec 12 04:22 PM
Gozani ShaiPresident & CEODec 11Buy1.702,0003,39151,196Dec 11 04:19 PM
Gozani ShaiPresident & CEODec 08Buy1.723,0005,15449,196Dec 08 04:14 PM
HIGGINS THOMAS TSenior Vice President, CFODec 08Buy1.682,0003,36924,963Dec 08 04:14 PM
HIGGINS THOMAS TSenior Vice President, CFODec 07Buy1.512,0003,02622,963Dec 07 04:22 PM
Gozani ShaiPresident & CEODec 07Buy1.506,3339,50646,196Dec 07 04:22 PM
Gozani ShaiPresident & CEODec 01Buy1.703,0005,10039,863Dec 01 04:23 PM
Gozani ShaiPresident & CEONov 16Buy1.942,0003,88736,863Nov 16 04:01 PM
Gozani ShaiPresident & CEOOct 25Buy1.675,0008,35434,863Oct 25 04:43 PM
HIGGINS THOMAS TSenior Vice President, CFOOct 25Buy1.702,5004,25220,963Oct 25 04:14 PM
Gozani ShaiPresident & CEOOct 24Buy1.732,5004,33129,863Oct 24 05:09 PM
HIGGINS THOMAS TSenior Vice President, CFOOct 23Buy1.772,5004,42018,463Oct 23 04:13 PM